StockTipsArenaBeta

BUY GlaxoSmithKline Pharmaceuticals Limited — Ansh Jogendra Bhilwar

BUYGlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals share price target & all analyst calls

byAnsh Jogendra BhilwarHorizon: 1–3 months11 Nov 2026via Zee Business (Live)

Entry₹2,751Inferred
Target₹3,000
Total upside +9.05%
Stop lossNot given
CMP₹2,672.61d ago
Active-2.85%+12.25%upside left 3 mo left
Follow Ansh Jogendra Bhilwar for new calls(42% target hit, 33 closed calls)Get alertsWatch GLAXO for new buy/sell callsGet alertsSee 1 other Short-term call on GLAXOSee 83 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:30 am IST
12 supporting1 opposing
Supports the BUY call (12)

MACD above its signal line — bullish momentum

Technicals · macd·14 Nov · today

Past month's volume 1.4× the prior month's average

Technicals · volume·13 Nov · yesterday

GSK Pharma Q2FY27 profit up 31% to ₹334.6 crore; underlying growth 12-13%

NewsGoogle News·8 Nov · 6d ago

(opens in new tab)

GlaxoSmithKline Pharmaceuticals Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

NewsGoogle News·7 Nov · 1w ago

(opens in new tab)

2 advisors have active long-term BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·6 Nov · 1w ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

RSI at 70 — overbought territory

Technicals · rsi·14 Nov · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on GlaxoSmithKline Pharmaceuticals

All analyst calls on GlaxoSmithKline Pharmaceuticals

More from Ansh Jogendra Bhilwar

Every call and its outcome